Introduction
Under normal physiologic conditions, mitochondrial β-oxidation is quantitatively the most important pathway for fatty acid catabolism. Besides mitochondrial β-oxidation ((80% of long-chain fatty acids (LCFA) up to 22 carbons)), β-oxidation of long-chain (for about 20%) and that of very-long chain fatty acids (VLCFA, > 22 atoms of carbon) occurs within the peroxisome [1] . Similar to mitochondrial β-oxidation, peroxisomal β-oxidation can be divided into different steps, involving multiple enzymes that sequentially act. Some of these enzymes (fatty acyl-CoA oxidase, peroxisomal D-3-hydroxyacyl-CoA hydratase/D-3-hydroxyacylCoA dehydrogenase ((D-PBE)) and peroxisomal 3-ketoacyl-CoA thiolase) are considered to be much more prone to oxidize straight-chain fatty acyl-CoAs. In rodents, two closely related genes, namely Thiolase a (Tha) and Thiolase b (Thb) have been cloned and characterized, while in humans only a single gene encoding for a peroxisomal 3-oxoacyl-CoA thiolase has been reported so far [2] [3] [4] . An infant girl with a deficiency in peroxisomal 3-ketoacyl-CoA thiolase has been initially reported [5] . However, close reinvestigation of this patient identified the true defect at the level of d-bifunctional protein [6] . Thus, whether human patients with alterations at the level of the peroxisomal 3-ketoacyl-CoA thiolase exist still remains an open question.
Other and/or similar peroxisomal enzymes such as branched-chain fatty acyl-CoA oxidase, D-PBE and sterol carrier protein2/3-ketoacyl-CoA thiolase (SCP2/SCPx) are rather devoted to the oxidation of branched-chain fatty acyl-CoAs.
Besides LCFAs and VLCFAs, 2-methyl-branched-chain, dicarboxylic fatty acids, eicosanoids and bile acids derivatives have been shown to be also metabolized within the peroxisomal matrix, extending the importance of the peroxisome. In agreement with the critical role of the peroxisome in lipid metabolism, absence of a single enzyme of the peroxisomal β-oxidation system has been shown to be associated with serious plasma lipid disorders, as shown by the hal-00495612, version 1 -28 Jun 2010 marked elevation of plasma VLCFAs levels in patients suffering from Acox-1 deficiency [7] .
Ablation of the Acox-1 gene in mice also revealed the critical role of this enzyme in lipid metabolism, since Acox-1 null mice suffered from a pronounced fatty liver which was associated with the constitutive activation of prototypical PPARα target genes and a spontaneous peroxisome proliferation [8] . Besides Acox-1, other mouse models deficient for a single peroxisomal enzyme have been established over the past few years. It was recently found that mice deficient for Mfp-2 displayed a coordinated induction of the transcription factors PPARα and SREBP2 [9] . In turn, the expression of typical SREBP2 and PPARα target genes was markedly induced in the liver of Mfp-2 -/-mice, leading to decreased levels of plasma triglycerides (TG) and free fatty acids (FFA) in adult mice. Others studies indicate that lack of Scp-x thiolase gene (Sterol Carrier Protein) only was enough to decrease ability of the mutant mice to metabolize branched-chain lipids [10] . With respect to the double loss of Sterol Carrier Protein X/ Sterol Carrier Protein-2, null mice displayed alteration in the peroxisomal β-oxidation of 2-methyl-branched chain fatty acids [11] . Further investigations also led to the finding that SCPx/SCP2 thiolase was involved in the conversion of cholesterol into bile acids [12] .
A deficient mouse model for ThB was previously generated and partially characterized, yet the in vivo role of ThB still remains ill defined [13] . In order to close in on the potential in vivo relevance of ThB, we studied WT and Thb -/-mice fed or not the potent PPARα agonist Wy14,643 (Wy). The nuclear hormone receptor PPARα plays a pivotal role in fatty acid handling by up-regulating the expression of numerous genes involved in mitochondrial and peroxisomal oxidation [14] . Here, exposure of mice to Wy is expected to markedly stimulate peroxisomal FAO and Thb mRNA levels in WT mice and not or less in Thb -/-mice, thus helping in the identification and characterization of the roles of ThB in vivo.
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Our main finding is that exposure of Thb -/-mice to Wy leads to a significant elevation of the hepatic content of MUFA n-7 and n-9 fatty acids, secondary to the induction of the microsomal SCD1 enzyme, through a likely SREBP1 independent manner.
Materials and methods

Animal experiments
All mice were on a pure-bred Sv129 genetic background. Male animals were kept in normal cages with food and water ad libitum. Mice were routinely fed a commercial and standard pellet diet (UAR A03-10 pellets from Usine d'Alimentation Rationnelle, Epinay sur Orge, France, 3.2 kcal/g) consisting (by mass) about 5.1% of fat (± 0.89% of C16:0, ± 0.09% of C16:1n-7, ± 0.45% of C18:0, ±1.06% of C18:1n-9, ±1.53% of C18:2n-9 and traces of C18:3n-9). At the time of sacrifice, animals were around 4-5 months of age. Male mice in the fasted state were deprived of food for 6h starting at 4:0 pm. Blood was collected via cardiac or orbital puncture into EDTA tubes. Tissues were excised, weighted and immediately frozen in liquid nitrogen before being stocked at -80°C. The animal experiments were approved by the animal experimentation committee of the University of Burgundy (protocol number n°1904) and were performed according to the European Union guidelines for animal care.
Chemicals
Wy14,643 (Wy) was obtained from ChemSyn Laboratories (Lenexa, Kanasa). SYBR green was from Eurogentec. Standards for fatty acids measurement by HPLC were from Sigma or Larodan. Pentafluorobenzyl bromide, N,N'-diisopropylethylamine, potassium hydroxide and BHT were from Sigma. All solvents were HPLC grade. hal-00495612, version 1 -28 Jun 2010
Histology and neutral fat staining
Haematoxylin and Eosin staining of liver sections were done using standard protocols.
Histology was examined on frozen sections after Oil Red O staining for neutral lipid using standard procedures.
Liver triglycerides
Total lipids from liver were extracted with chloroform/methanol (2/1 v/v) according to the method of Folch. Glyceryl triheptadecanoate as an internal standard was added for quantification. Triglycerides were separated by thin layer chromatography (TLC) using hexane/ethylique ether/acetic acid (90/30/1 v/v/v) as solvent. The triglycerides were then scaped and extracted from silica gel with chloroform/methanol (9/1 v/v). The total fatty acids of triglycerides were methylated and quantified by Gas Chromatography (GC) using a Chrompack CP 9002 Gas Chromatograph equipped with a Varian FactorFour VF-23ms capillary column (30mx0,32mm).
Liver and plasma Fatty Acid Profile
10 mg of liver (or 50 µl of plasma) was saponified with 1 ml of ethanolic potassium hydroxide (final concentration 0.6N) containing 10 µg of heptadecanoic acid and 250 ng of tricosanoic acid as internal standards and 50 mg/L of butylated hydroxytoluene. The tubes were incubated at 56°C for 45 min. After incubation, fatty acids were extracted by adding 1 ml of 1.2 M HCl and 2 ml of hexane to each tube. The tubes were shaken at room temperature for 5 mn, centrifuged and the organic phase was evaporated to dryness under nitrogen and derivatized to pentafluorobenzyl esters with 100 µl of acetonitrile, 5 µl of pentafluorobenzyl bromide and 5 µl of diisopropylethylamine at room temperature for 30 min. One ml of water was added and derivatives were extracted with 2 ml of hexane. After centrifugation, the organic phase was evaporated and 100 µL of hexane were added. One µl was further injected hal-00495612, version 1 -28 Jun 2010 in the split mode. Quantification of liver and plasma fatty acid esters was performed using a 
Lipoprotein profiling
Lipoproteins were separated using fast protein liquid chromatography (FPLC) on a Superose 6 HR 10/30 column (Amersham Biosciences) as described previously [15] .
Preparation of nuclear and microsomal fractions of liver
Nuclear and cytosolic fractions of liver were prepared as previously published [16] .
Concerning microsomal fractions, pooled excised livers (100mg for each animal) were thawed, finely chopped and homogenized in ice cold 10 mM Tris-HCl buffer pH 7.4 containing 0.25 M sucrose and 1 mM EGTA, in a Potter glass homogenizer equipped with a Teflon pestle. Pooled homogenates were centrifuged at 4350 g for 3 min at 4°C. The precipitate was discarded and supernatant was again centrifuged at 22 000g for 5 min (4°C).
Supernatant was collected and further centrifuged at 100 000g for 5 min in a Beckman airfuge hal-00495612, version 1 -28 Jun 2010 ultracentrifuge. Pellet was suspended in 100 µl of the upper pre-cited buffer. Protein estimation of each preparation was done using Bradford's method.
Plasma metabolites
Plasma was initially collected into EDTA tubes via retro-orbital punctures and then centrifuged at 4°C (10 min, 6000 rpm). Plasma cholesterol and triglyceride concentration were determined using kits from Diasys (Diagnostic Systems International, France).
RNA Isolation and RT-PCR
RNA from liver was extracted with Trizol reagent (Invitrogen) using the supplier's instructions. RNA was then further purified (from free nucleotides and contaminating genomic DNA) using RNeasy columns (Qiagen) with DNAse treatment. 1 µg of RNA was used for reverse transcription with iScript Reverse Transcriptase (Biorad).
Real Time Quantitative PCR
PCR reactions were performed using the qPCR MasterMix Plus for SYBR Green I with fluorescein (Eurogentec). All PCR reactions were performed with MultiGuard Barrier Tips (Sorenson BioScience, Inc.) and an iCycler PCR machine (Bio-Rad Laboratories). Primers were designated to generate a PCR amplification product of 100-200 bp and were selected according to indication provided by the Primer 3 software (http://frodo.wi.mit.edu/cgibin/primer3/primer3_www.cgi). Sequences are available from S.M. on request. Specificity of the amplification was verified by melt curve analysis and evaluation of efficiency of PCR amplification. The "delta-delta Ct" quantification method was used and expression was related to the control gene 36B4, which did not change under any of the experimental conditions studied.
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Immunoblot
Immunoblotting on liver samples was carried out as described previously [17, 18] . Scd1 (sc-14720, 1:200), Srebp1 (sc-366, 1:200), histone H4 (sc-10810, 1:2000) antibodies were all purchased from Santa Cruz Biotechnology.
Statistical analyses
The ANOVA one way test was used to calculate statistically significant differences.
Results
Hepatic mRNA levels of PPARα target genes are normal in Thb
-/-mice.
It was previously reported that the isolated deletion of peroxisomal enzymes such as ACOX-1, MFP-2 or SCPx was associated with a constitutive expression of typical PPARα target genes in the liver, supporting the hypothesis that substrates of these enzymes are putative natural ligands for PPARα [9, [19] [20] [21] . Hence, using quantitative RT-qPCR, we checked suggest that the deletion of Thb was not associated with a significant impairment of the hepatic PPARα signaling cascade.
Hepatic and plasma cholesterol are normal in Thb
Under a normal laboratory chow, mice deficient for other peroxisomal enzymes such as Mfp-2
or Scp2 genes displayed a steady-state level of hepatic and plasma cholesterol [9] . Here, we first wondered what could be the consequence of Thb deletion on these parameters. It was found that 6h-fasted Thb -/-mice (previously fed or not with Wy) displayed normal plasma cholesterol contents, suggesting that Thb is dispensable for cholesterol homeostasis in mice ( Fig. 2A) . Profiling of lipoproteins using FPLC analysis confirm the lack of differences in VLDL and HDL cholesterol fractions (Fig. 2B ). Quantification of liver cholesterol content by gas chromatography also revealed that ablation of Thb has no strong consequences on hepatic cholesterol load (Fig. 2C ).
Wy reverses the reduced hepatic TG content observed in Thb -/-mice
To check whether ablation of Thb may increase plasma triglycerides (TG) content through increase of lipoprotein secretion, plasma TG levels were evaluated, in 6h fasted WT and Thb -/-mice, previously fed or not with Wy ( Fig. 3A ). Plasma TG levels were similar for both genotypes. Profiling of lipoproteins using FPLC analysis confirm the lack of differences in VLDL and LDL TG fractions (Fig. 3B ). Together, our data indicate that ThB is not critical for the maintenance of normal circulating TG levels under a normal regulatory laboratory chow.
Because it was previously reported that mice deficient for the peroxisomal Acox-I gene displayed a pronounced hepatic fatty liver under a normal laboratory chow, a survey of liver TG contents was performed in WT and Thb -/-mice, fed or not Wy [9] . It was found that hepatic TG contents were lower in Thb -/-mice, indicating that ThB can not be fully compensated by other peroxisomal thiolases (Fig. 3C ). Wy is known to activate PPARα that
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in turn promotes FAO and shifts away part of fatty acids from esterification and storage. In agreement, it was found that Wy feeding lowered TG contents in liver of WT mice (Fig. 3C ).
Of interest, when combining Thb deletion and Wy treatment, hepatic TG content was not reduced suggesting that the hypotriglyceridemic effect of Wy was blunted. This was further confirmed by Oil red O staining of liver sections (Fig. 4A ). In line with a similar increase of the relative liver mass upon Wy treatment in WT and Thb -/-mice (data not shown), the size of hepatocytes from both genotypes appeared to be equally enlarged by Wy, indicating similar hepatomegaly (Fig. 4B ). and Fas (2-fold) was found in Thb -/-mice fed Wy (Fig. 5A) . Srebp1c mRNA levels in liver have been shown to be under the control of Lxrα, yet Lxrα mRNA levels remained unchanged ( Fig. 5A ) [22] . Chrebp mRNA levels that codes for the carbohydrate response element binding protein (ChREBP) were also unaltered following Thb deletion (Fig. 5A) 5B ). Given that SREBP1c is the predominant isoform of SREBP1 in the liver, we believed that the amount of nuclear SREBP1c was likely not altered by Thb deletion and Wy. Interestingly, although not significant, Scd1 mRNA levels also tended to be higher in the liver of Thb -/-mice fed Wy (Fig. 5A) . Under normal conditions, protein content of liver SCD1 (microsomal fraction only) was below the detection level of the antibody used for western-blotting (Fig. 5C ). Yet, following Wy treatment, SCD1 protein content was comparatively much elevated in Thb -/-mice, indicating that ThB is likely indirectly involved in the control of SCD1 expression (Fig. 5C ). hal-00495612, version 1 -28 Jun 2010
Elevated liver TG observed in
Lack of Thb modulates hepatic and plasma MUFA n-7 and n-9 concentrations as well as PUFA n-3
Given its critical role in VLCFA oxidation, peroxisome appears to be essential for lipid homeostasis as shown by the high plasma and/or hepatic concentrations of straight-chain VLCFAs (C24:0, C26:0, C26:1) observed in patients/mice suffering from isolated defects in peroxisomal enzymes [7, 8, 23] . We then decided to perform a complete analysis of medium-to long-chain fatty acid species (C:12-C:20) as well as of VLCFA (C:22-C:26) present in liver and plasma of WT and Thb -/-mice (fed or not Wy). Noteworthy, it was found that upon Wy activation, Thb -/-mice displayed a significant enrichment of liver MUFA n-7 and n-9, among which C16:1n-7, C18:1n-7, C16:1n-9 and C18:1n-9 (Table 1) . In mammalian liver, SCD1 is the main enzyme responsible for the conversion of palmitoyl-CoA (C16:0, the saturated fatty acid products of FAS) and stearoyl-CoA (C18:0) to palmitoleyl-CoA (C16:1n-7) and oleylCoA (C18:1n-9), respectively. Supporting the hypothesis of enhanced lipogenesis partially by SCD1 in Thb -/-mice fed Wy, the desaturation index of total liver lipids, which is considered to reflect SCD1 activity, was significantly increased (Fig. 6A ) [24] . Besides C16:1 and C18:1 as well as hepatic MUFA (n-7 and n-9) contents such as C20:1n-7, C20:1n-9, C22:1n-7, C22:1n-9 and C24:1n-7 were more elevated in Thb -/-mice fed Wy compared to corresponding control mice, it suggests that lack of Thb favored the emergence of MUFAs (Table 1) .
With respect to PUFA, it was found that deletion of Thb alone was sufficient to increase C18:3n-3, C20:3n-3, C20:4n-3, C20:5n-3 and C22:5n-3 fatty acids in liver and partially for some of them in plasma (Table 2 and supplementary data, Table 4 ). Increased levels of these fatty acids can reflect reduced peroxisomal β-oxidation, which consecutively may provide more substrates for the microsomal fatty acid elongation system. Alternatively, enhanced activity of elongases might be secondary to increased gene expression. To check for this, mRNA levels of several elongases/desaturases were quantified using hepatic samples of WT
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and Thb -/-mice, fed or not Wy (Fig. 6B) 
Ablation of Thb is associated with decrease levels of hepatic C26:0 contents
Supporting a defect in peroxisomal β-oxidation of fatty acids in Thb -/-mice fed Wy, hepatic C22:6n-3/C24:6n-3 ratio was strongly reduced (-50%) ( Table 2 ). This point is important because production of C22:6n-3 from C24:6n-3 necessarily implies a reduction of 2C by an obligatory process that involves peroxisomal β-oxidation. We concluded that deletion of Thb functionally impacts on peroxisomal β-oxidation and then can not be fully compensated by
ThA or SCPx/SCP2 thiolase in vivo. In agreement with a similar oxidation rate of palmitate in WT and Thb -/-mice at baseline, C22:6n-3/C24:6n-3 ratio was unaffected by Thb deletion alone, pointing out that the effects of Thb deletion need to be elicited by activators of peroxisomal FAO (such as Wy).
With regard to VLCFAs such as C22:0 and C24:0, both hepatic and plasma contents were similar in WT and Thb -/-mice fed or not Wy (Table 3 and supplementary data in Table 4 ).
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Intriguingly, decreased C26:0 levels were observed in hepatic samples of Thb -/-mice fed Wy, leading to decreased hepatic C26:0/C22:0 and C26:0/C24:0 ratios.
Severe peroxisomal disorders have also been associated with the elevated plasma and/or tissue levels of branched-chain phytanic/pristanic acids and bile acids precursors [11, 25] . One prominent theory also suggests that ThB and ThA would preferentially oxidize long-straight chain fatty acids while branched-chain very long chain fatty acids would rather be substrates for SCPx/SCP2 thiolase. To verify whether lack of Thb could modulate plasma branchedchain fatty acids levels, plasma pristanic and phytanic acids levels were then assessed in WT
and Thb -/-mice fed or not Wy (supplementary data in Table 5 ). None of the branched-chain fatty acids levels were significantly different between the four groups of mice. While other additional investigations are needed to reach a firm conclusion, these results suggest that ThB is not critical for maintaining branched-chain fatty acids levels in a normal range. Together, our data support the hypothesis that ThB is somehow involved in hepatic C26:0 homeostasis in mice, through a biochemical route that remains ill defined.
Discussion
Little is known about the roles of Thb in mice, hence a mouse model deficient for the Thb gene has been previously established in the laboratory [13] . However, the first characterization of the phenotype was rather incomplete. We now provide a more detailed analysis of the Thb deficient mouse model by showing that at baseline, hepatic peroxisomal FAO was not altered by Thb deletion as shown by the ratio of C22:6n-3 / C24:6n-3 (liver and plasma) that remained similar. Hence, ThA and/or SCPx/SCP2 thiolase may act on behalf of ThB under basal conditions. After Wy feeding, the situation is somewhat different as shown by the amplitude of the peroxisomal FAO activation which is comparatively reduced (-30%) in Thb -/-mice (Fidaleo et al, in preparation).
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Although seemingly paradoxical, Thb -/-mice displayed reduced hepatic TG content which is associated with increased levels of C20:3n-3, C20:5n-3 and C22:5n-3, both in liver and plasma. Hence, the deletion of Thb alone leads to alterations in lipid metabolism in liver through a likely PPARα-independent manner. Supporting this, the mRNA levels of hepatic typical PPARα regulated genes was not altered by Thb deletion alone. Further, no spontaneous hepatomegaly or peroxisome proliferation, two biological processes that are largely under the positive control of PPARα, could be observed in Thb -/-mice [26] . Decreased lipogenesis and hepatic TG content have been shown to be possibly secondary to the action of some dietary PUFAs n-3 such as C20:5n-3, through the modulation of the proteolytic maturation of SREBP1c. However, in spite of the elevation of C20:5n-3 in the liver of Thb -/-mice, we have provided some evidence that the SREBP1 maturation was likely not impaired. Hence, the precise molecular mechanism that governs the decrease of TG in liver of Thb -/-mice still remains mysterious.
Up-regulation of Thb mRNA in liver of WT mice by Wy was associated with decreased hepatic TG levels, while deletion of Thb hampered the hypotriglyceridemic action of Wy. The combination of decreased peroxisomal FAO and increased fatty acid synthesis likely accounts for the higher concentration of TG in the liver of Thb -/-mice fed Wy. In support of an indirect role of ThB in hepatic lipogenesis, an increased content of MUFA n-7 and n-9 fatty acids in the liver of Thb -/-mice fed Wy was found, probably because of higher hepatic SCD1 protein content and activity. MUFA have been described as the preferred substrates for TG synthesis [27] . Considering that esterification of MUFA n-7 and n-9 to the glycerol backbone is not [33] . Illustrative for this hypothesis is that glucocorticoids have been shown to activate Pparα , Elovl3 and Scd1 mRNA levels in liver [34, 35] . It can then be reasonably hypothesized that the hormonal status may be changed by Thb deletion and further aggravated by Wy feeding [33] . Up till now, Pparα is not known to be auto-regulated in liver, hence the hypothesis of increased stress metabolites in the plasma of Thb -/-mice fed Wy, that in turn would up-regulate Pparα mRNA levels in liver, is strengthened [34, 35] .
X-linked adrenoleukodystrophy (X-ALD), the most common peroxisomal disorder reported to date, is biochemically characterized by elevated plasma and tissue levels of straight-chain saturated fatty acids and VLCFAs such as C24:0, C26:0 and C26:1 [36] . In agreement with a functional peroxisomal β-oxidation under basal condition, Thband plasma concentrations of these three metabolites. Following Wy activation, liver C26:0 levels were comparatively reduced in Thb -/-mice while those of C24:0 remained unaltered.
Hepatic reduction of C26:0 was accompanied by a significant accumulation of n-7 and n-9
MUFA. Others have previously found that cholesterol-deprivation increases MUFA in skin fibroblasts from patients with X-ALD, yet liver as well as plasma cholesterol concentrations were unaltered by Thb deletion and Wy feeding, ruling out at first, this hypothesis [37] .
Of interest, Rizzo et al have previously demonstrated that incubation of cultured skin fibroblasts (X-ALD) with oleic acid (C18:1) and erucic acid (C22:1) normalized C26:0 levels, paving novel roads for therapies based on the oral administration of a dietary mixture composed of C22:1 and C18:1 fatty acids (commonly referred as "Lorenzo's oil") [38] .
Hence, we propose that enrichment of MUFA (particularly that of C18:1n-7, C18:1n-9, C22:1n-7, C22:1n-9) observed in Thb -/-mice mice fed Wy might protect from aberrant increase of hepatic C26:0 contents. In conclusion, in the normal fed state deletion of Thb favors the emergence of some PUFA n-3. Following activation of FAO by the peroxisome proliferator Wy, deletion of Thb promotes accumulation of MUFA n-7 and n-9 via the activation of SCD1. One of the most pressing challenges is to check whether this finding can be translated from rodents to humans, in which only a single gene has been identified so far [4] . Further studies that aim at delineate the molecular connection between ThB and SCD1 are also awaited to better define the impact of Thb deletion in the regulation of cell growth and membrane fluidity signal transduction which are all pathways known to be modulated by MUFA n-7 and n-9. Liver RNA was isolated and RT-qPCR was performed. Error bars represent SEM (n=5).
Differences between WT and Thb-/-mice fed Wy were evaluated using one-way Anova; * p<0.05, **p<0.01; Gene expression levels from the animals receiving vehicle only were set at (a) 6h-fasted WT and Thb-/-mice previously fed or not with Wy for 8-days were used. Liver RNA was isolated and RT-qPCR was performed. Error bars represent SEM (n=5).
Differences between WT and Thb -/-mice fed Wy were evaluated using one-way Anova; * p<0.05, **p<0.01; Gene expression levels from the animals receiving vehicle only were set at Fatty acid composition (mass %) of total PUFAs in liver of 5-month-old mice. Values are expressed as mean ± SEM. Significant differences between both genotypes were evaluated with Anova one way test. * p<0.05; ** p<0.01; *** p<0.001. Table 3 .
Fatty acid composition (mass %) of total Saturated FAs in liver of 5-month-old mice. Values are expressed as mean ± SEM. Significant differences between both genotypes were evaluated with Anova one way test. * p<0.05; ** p<0.01; *** p<0.001.
Supplementary data, Table 4 .
Fatty acid composition (mass %) of total Fatty Acids in plasma of 5-month-old mice. Values are expressed as mean ± SEM. Significant differences between both genotypes were evaluated using the one-way Anova test. * p<0.05; ** p<0.01; *** p<0.001. In bold, saturated and monounsaturated fatty acids related, as precursors or substrates, to Scd1.
Supplementary data, Table 5 .
Plasma levels pristanic and phytanic acids, as determined by GC-MS. Values are expressed as mean ± SEM. Differences between both genotypes were evaluated using the one-way Anova test.
Arnauld et al., Figure 1 fold-change Arnauld et al., Table 1 hal-00495612, version 1 -28 Jun 2010
Arnauld et al., 
